Send to

Choose Destination
J Surg Oncol. 1995 Jun;59(2):86-92; discussion 92-3.

Studies of rhodamine-123: effect on rat prostate cancer and human prostate cancer cells in vitro.

Author information

Huntington Medical Research Institutes, Pasadena, CA 91101, USA.


The effect of the lipophilic, cationic dye, Rhodamine-123 (Rh-123), on prostate cancer in rats, and on three tumor cell lines in vitro is reported here. The general toxicity of Rh-123 in mice has been found to be minimal. Lobund-Wistar (L-W) rats with the autochthonous prostate cancer of Pollard were treated for six doses with Rh-123 at a dose of 15 mg/kg subcutaneously every other day. Microscopic examination of the tumors revealed cellular and acinar destruction. The effectiveness of Rh-123 as a cytotoxic agent was tested by clonogenic and viability assays in vitro with three human prostate cancer cell lines. Severe (60-95%) growth inhibition was observed following Rh-123 exposure for 2-5 days at doses as low as 1.6 micrograms/ml in all three prostate cancer cell lines.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center